<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28104">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02740855</url>
  </required_header>
  <id_info>
    <org_study_id>Endtidal ethanol</org_study_id>
    <nct_id>NCT02740855</nct_id>
  </id_info>
  <brief_title>Endtidal Ethanol in Sclerotherapy</brief_title>
  <official_title>Endtidal Ethanol in Sclerotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <brief_summary>
    <textblock>
      During the ethanol sclerotherapy procedure, the investigators will record doses of and time
      of ethanol injections and record ethanol concentrations in endtidal breath every 5 minutes.
      Furthermore after every ethanol injection the concentration will be measured every minute
      for 5 minutes. To do so, the investigators will attach a breath alcohol testing device to
      the expiratory carbon dioxide measuring unit. Since this is the new standard of the
      university hospital Berne all patients undergo the same procedure. There is no study
      specific intervention. In this study the investigators will only document the breath alcohol
      levels, doses and timing of ethanol injections. All other data will be obtained from the
      anesthesia information system. During the two months of the study, the investigators will
      also record endtidal ethanol concentration after anesthesia in the postoperative care unit
      discharge from the unit.

      The intention is to show the correlation between injected ethanol doses and measured
      endtidal ethanol concentration over the entire time of the intervention.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endtidal ethanol concentrations in mg/dl over time</measure>
    <time_frame>1 year 2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bloodpressure in mmHg over time</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bloodpressure in mmHg over injected peripheral ethanol volume</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse rate in beats er minute over time</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse rate in beats er minute over injected peripheral ethanol volume</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endtidal ethanol concentrations in mg/dl over injected ethanol volume</measure>
    <time_frame>1 year 2 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Ethanol Concentration</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alcomed 3011Â®</intervention_name>
    <description>Endtidal ethanol measurement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing ethanol sclerotherapy at the university hospital Berne over the
        age of 18.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing ethanol sclerotherapy at the university hospital Berne

        Exclusion Criteria:

          -  under the age of 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lorenz Theiler, PD Dr. med.</last_name>
    <phone>+41 31 6320804</phone>
    <email>lorenz.theiler@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bern University Hospital and University of Bern</name>
      <address>
        <city>Bern</city>
        <zip>3011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenz G Theiler, MD</last_name>
      <phone>+41 (31) 632 2111</phone>
      <phone_ext>7837</phone_ext>
      <email>lorenz.theiler@insel.ch</email>
    </contact>
    <contact_backup>
      <last_name>Robert Greif, MD MME FERC</last_name>
      <phone>+41 (31) 632 2111</phone>
      <phone_ext>7848</phone_ext>
      <email>robert.greif@insel.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 9, 2017</lastchanged_date>
  <firstreceived_date>April 5, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sclerotherapy</keyword>
  <keyword>ethanol</keyword>
  <keyword>pulmonal hypertension</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
